Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review
Gregory Reardon1, Sameer Kotak2, Gail F Schwartz3 1Informagenics, LLC, Worthington, OH, USA; The Ohio State University College of Pharmacy, Columbus, OH, USA; 2Pfizer Inc, New York, NY, USA; 3Glaucoma Consultants, Greater Baltimore Medical Center; Wilmer Eye Institute, Johns Hopkins University, Balt...
Main Authors: | Reardon G, Kotak S, Schwartz GF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-09-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/objective-assessment-of-compliance-and-persistence-among-patients-trea-a8344 |
Similar Items
-
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
by: Schwartz Gail F, et al.
Published: (2010-03-01) -
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
by: Kotak Sameer, et al.
Published: (2011-06-01) -
Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone
by: M Selim Kocabora, et al.
Published: (2008-03-01) -
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
by: Gregory Katz, et al.
Published: (2010-11-01) -
The prevalence of ocular surface complaints in Brazilian patients with glaucoma or ocular hypertension
by: Vital Paulino Costa, et al.
Published: (2013-08-01)